Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Oral Semaglutide

OASIS 4

Novo Nordisk · Phase 3 · Completed · Enrollment 307

NCT05564117

EudraCT 2021-006534-40

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Oral semaglutide 25 mg95 participants63 participants36 participantsn/r0
Oral semaglutide placebo19 participants6 participants9 participantsn/r0

A count stays a count. This page does not turn a count into a percent.